EPISODE · Feb 22, 2022 · 53 MIN
BCMA-Directed Therapy in Multiple Myeloma: Assessing the Clinical Impact
from Keeping Current CME
Our panel of myeloma experts highlight the BCMA antigen and its role as a therapeutic target in multiple myeloma. Credit available for this activity expires: 2/18/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/968684?src=mkm_podcast_addon_968684
Embed this episode
NOW PLAYING
BCMA-Directed Therapy in Multiple Myeloma: Assessing the Clinical Impact
0:00
53:15
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 53 minutes long.
When was this Keeping Current CME episode published?
This episode was published on February 22, 2022.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!